– Achieved Full Year 2021 Preliminary Global Net Product Revenues of $662 Million, Representing 83% Annual Growth Compared to 2020 – – Maintained Strong Balance Sheet with Year-End Cash and Investments Balance of Approximately $2.4 Billion – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth quarter […]
Plant medicines are incredibly useful, but difficult for researchers to understand due to a mixture of functions. For example, a new study discovered an intricate relationship between certain terpenes, THC, and pain management. According to a new study, terpenes interact with the endocannabinoid system (ECS) depending on the type of injury — for better or […]